Antiretroviral composition

A technology of anti-retrovirus and composition, which can be used in anti-viral agents, drug delivery, microcapsules, etc., and can solve expensive problems

Inactive Publication Date: 2015-03-11
CIPLA LTD
View PDF8 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, all such techniques involve the use of complex methods or systems and are expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antiretroviral composition
  • Antiretroviral composition
  • Antiretroviral composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0152] method:

[0153] (1) Prepare a dry mixture of lopinavir, ritonavir and colloidal silicon dioxide.

[0154] (2) Add sorbitan monolaurate to the copovidone in a suitable granulator to form a polymer premix separately.

[0155] (3) Mix the dry mixture obtained in step (1) and step (2) in a suitable granulator and melt extrude (hot).

[0156] (4) Colloidal silicon dioxide was mixed with dry granules and lubricated by using sodium stearyl fumarate.

[0157] (5) Compress the lubricated granules into microtablets.

[0158] (6) Coat the compressed microtablets with a seal coat solution.

[0159] (7) Filling the microtablets obtained in step (6) into hard gelatin capsules.

Embodiment 2

[0161]

[0162] method:

[0163] 1. Prepare a dry mixture of ritonavir, colloidal silicon dioxide and Eudragit.

[0164] 2. Extrude the dry mixture obtained in step (1) using a hot-melt extrusion technique.

[0165] 3. The extrudate obtained in step (2) is sized and sieved to form granules.

[0166] 4. Mix the granules obtained in step (3) with colloidal silicon dioxide and sugar.

Embodiment 3

[0168]

[0169] method:

[0170] 1. Prepare a dry mixture of ritonavir, colloidal silicon dioxide, sugar and Eudragit.

[0171] 2. Extrude the dry mixture obtained in step (1) using a hot-melt extrusion technique.

[0172] 3. The extrudate obtained in step (2) is sized and sieved to form granules.

[0173] 4. Add colloidal silicon dioxide and mix the granules obtained in step (3).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

The present invention provides a pharmaceutical solid oral sprinkle composition comprising one or more antiretroviral drugs, and a method of manufacturing the same. The present invention is particularly useful for treatment of an HIV infection, AIDS related complex, or AIDS.

Description

field of invention [0001] The present invention relates to a solid oral sprinkle pharmaceutical composition comprising one or more antiretroviral drugs such as ritonavir, a process for its preparation and the use of said composition in the treatment of diseases caused by retroviruses , especially the use of acquired immunodeficiency syndrome or HIV infection. In particular, the invention relates to sprinkle formulations comprising one or more antiretroviral drugs such as ritonavir. Background technique [0002] Acquired immunodeficiency syndrome (AIDS) results in a gradual breakdown of the body's immune system and progressive deterioration of the central and peripheral nervous systems. Two different retroviruses, human immunodeficiency virus (HIV) type 1 (HIV-1) or type 2 (HIV-2), have been etiologically associated with this immunosuppressive disease, acquired immunodeficiency syndrome (AIDS) associated. HIV seropositive individuals are initially asymptomatic but often de...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/16A61K9/20A61K31/427A61K31/513
CPCA61K31/513A61K9/2072A61K31/427A61K9/1611A61K45/06A61K9/1635A61K31/426A61P31/18A61K2300/00A61K9/0053A61K9/1617A61K9/1623A61K9/5073A61K9/5084A61K9/5089
Inventor S·M·普兰德尔G·马尔霍特拉
Owner CIPLA LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap